TLDR Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.
This study investigated the role of androgen receptor CAG polymorphism and hormone levels in the severity of COVID-19 among 142 male patients. It found that a higher number of CAG repeats in the androgen receptor gene correlated with increased disease severity, with the percentage of patients having more than 23 repeats doubling from Grade I to Grade IV severity. Additionally, lower testosterone levels were observed in patients with severe disease. The findings suggested that reduced androgenic signaling, characterized by low testosterone and reduced receptor activity, could predispose men to severe COVID-19 by triggering an excessive inflammatory response, leading to multi-organ damage.
4 citations
,
March 2022 in “Journal of Infection” Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.
16 citations
,
December 2021 in “Frontiers in Endocrinology” Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.
38 citations
,
May 2021 in “International Journal of Infectious Diseases” 
121 citations
,
November 2020 in “Endocrine” Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.
26 citations
,
September 2020 in “Journal of the European Academy of Dermatology and Venereology” A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.
71 citations
,
April 2020 in “Journal of Cosmetic Dermatology” Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.
10 citations
,
February 2020 in “Endocrine” Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.
